Company Overview of Coulter Pharmaceutical, Inc.
Coulter Pharmaceutical, Inc. develops and markets drugs and therapies for the treatment of people with cancer and autoimmune diseases. The company offers monoclonal antibody-based anti-cancer drugs that hone in on tumor cells without devastating surrounding healthy tissues. The company was incorporated in 1995 and is based in South San Francisco, California. Coulter Pharmaceutical, Inc. operates as a subsidiary of GlaxoSmithKline plc.
600 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1995
Key Executives for Coulter Pharmaceutical, Inc.
Coulter Pharmaceutical, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Coulter Pharmaceutical, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.